Publications by authors named "Mark J Alberts"

Claim this Profile
P
Prioritizing gaps in stroke care: A two-round Delphi process.
Elke Ge Mathijssen, Jaap Ca Trappenburg, Mark J Alberts, Angelique Balguid, Robert J Dempsey

Eur Stroke J· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In ischemic stroke prevention, apixaban and aspirin do not differ for intracranial hemorrhage events.
Mark J Alberts,

Ann Intern Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In patients with subclinical AF, apixaban vs. aspirin reduced stroke or systemic embolism at 3.5 y in those with previous stroke or TIA.
Mark J Alberts,

Ann Intern Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In mild ischemic stroke or high-risk TIA, DAPT started ≤72 h after onset reduced new stroke and increased bleeding at 90 d.
Mark J Alberts

Ann Intern Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterogeneity of State Stroke Center Certification and Designation Processes.
Madeline Feldmeier, Anthony S Kim, Kori S Zachrison, Mark J Alberts, Yu-Chu Shen

Stroke· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In ischemic stroke without large or medium vessel occlusion, tirofiban increased likelihood of an excellent outcome.
Mark J Alberts

Ann Intern Med· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ischemic stroke and systemic embolism among patients with non-valvular atrial fibrillation who abandon oral anticoagulant therapy.
Mark J Alberts, Maryia Zhdanava, Dominic Pilon, Gabrielle Caron-Lapointe, Patrick Lefebvre

Curr Med Res Opin· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
After ICH, starting long-term therapeutic oral anticoagulation in patients with AF reduces MACE at 1 to 3 y.
Mark J Alberts

Ann Intern Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and Safety of Rivaroxaban versus Warfarin Among Nonvalvular Atrial Fibrillation Patients with Obesity and Polypharmacy.
Mark J Alberts, Jinghua He, Akshay Kharat, Veronica Ashton

Am J Cardiovasc Drugs· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying Best Practices to Improve Evaluation and Management of In-Hospital Stroke: A Scientific Statement From the American Heart Association.
Amre Nouh, Sepideh Amin-Hanjani, Karen L Furie, Walter N Kernan, DaiWai M Olson, Mark J Alberts

Stroke· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ischemic Stroke in Patients With Pulmonary Arteriovenous Fistulas.
Karan K Topiwala, Smit D Patel, Mubashir Pervez, Claire L Shovlin, Mark J Alberts

Stroke· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of Stroke Outcomes in Atrial Fibrillation Patients Treated with Rivaroxaban and Warfarin.
Dejan Milentijevic, Jennifer H Lin, Nancy Connolly, Yen-Wen Chen, Emily Kogan, Mark J Alberts

J Stroke Cerebrovasc Dis· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel GDF2 Gene Mutation Associated with Pulmonary Arteriovenous Malformation.
Karan K Topiwala, Smit D Patel, Amre M Nouh, Mark J Alberts

J Stroke Cerebrovasc Dis· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In ischemic stroke, thrombectomy alone was noninferior to thrombectomy plus alteplase for functional outcome at 90 days.
Mark J Alberts

Ann Intern Med· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and coronary or peripheral artery disease.
Craig I Coleman, William L Baker, Anna-Katharina Meinecke, Daniel Eriksson, Brandon K Martinez, Mark J Alberts

Eur Heart J Cardiovasc Pharmacother· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine learning provides evidence that stroke risk is not linear: The non-linear Framingham stroke risk score.
Agni Orfanoudaki, Emma Chesley, Christian Cadisch, Barry Stein, Amre Nouh, Mark J Alberts

PLoS One· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Burden-of-Illness Associated with Bleeding-Related Hospitalizations in Atrial Fibrillation Patients: Findings from the Nationwide Readmission Database.
Benjamin Miao, Monique Miller, Belinda Lovelace, Anne Beaubrun, Kelly McNeil-Posey, Mark J Alberts

TH Open· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Four-year incidence of major adverse cardiovascular events in patients with atherosclerosis and atrial fibrillation.
Benjamin Miao, Adrian V Hernandez, Yuani M Roman, Mark J Alberts, Craig I Coleman

Clin Cardiol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibition and Stroke Prevention: Another Step Forward.
Mark J Alberts, Paul D Thompson

Stroke· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and Predictors of Major Adverse Cardiovascular Events in Patients With Established Atherosclerotic Disease or Multiple Risk Factors.
Benjamin Miao, Adrian V Hernandez, Mark J Alberts, Nicholas Mangiafico, Yuani M Roman

J Am Heart Assoc· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In acute ischemic stroke with hyperglycemia, intensive vs standard glucose control did not improve 90-day outcomes.
Mark J Alberts

Ann Intern Med· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and effectiveness of oral factor Xa inhibitors versus warfarin in nonvalvular atrial fibrillation patients at high-risk for falls.
Benjamin Miao, Mark J Alberts, Thomas J Bunz, Craig I Coleman

J Thromb Thrombolysis· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations for the Establishment of Stroke Systems of Care: A 2019 Update.
Opeolu Adeoye, Karin V Nyström, Dileep R Yavagal, Jean Luciano, Raul G Nogueira, Mark J Alberts

Stroke· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost and inpatient burden of peripheral artery disease: Findings from the National Inpatient Sample.
Christine G Kohn, Mark J Alberts, W Frank Peacock, Thomas J Bunz, Craig I Coleman

Atherosclerosis· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dawn of a New Era for Stroke Treatment: Implications of the DAWN Study for Acute Stroke Care and Stroke Systems of Care.
Mark J Alberts, Martin D Ollenschleger, Amre Nouh

Circulation· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis